Zhenqian Qin

Prof. Zhenqian Qin

Jiangsu University, Zhenjiang, Jiangsu, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Life Sciences
Verified
Journal Article
Closed access
YXYimin Xie
Yimin Xie
XYXuefeng Yuan
Xuefeng Yuan
WZWeimin Zhou
Weimin Zhou
AKAnthony Adebayiga Kosiba
Anthony Adebayiga Kosiba
HSHaifeng Shi
Haifeng Shi
ZQZhenqian Qin
Zhenqian Qin

30 September 2022 in Cells
Verified
Journal Article
Open access
PDF file
CHchu hezhen
chu hezhen
ZQZhenqian Qin
Zhenqian Qin
MJma jun
ma jun
YXYimin Xie
Yimin Xie
HSHaifeng Shi
Haifeng Shi
SQshi bai qiang
shi bai qiang
The calcium-sensing receptor (CaSR), a G-protein-coupled receptor (GPCR), is a cell-surface-located receptor that can induce highly diffusible messengers (IP3, Ca2+, cAMP) in the cytoplasm to activate various cellular responses. Recently, it has also been suggested that the CaSR mediates the intracellular communications between the endoplasmic reticulum (ER), mitochondria, nucleus, protease/proteasome, and autophagy–lysosome, which are involved in related cardiovascular diseases. The complex intracellular signaling of this receptor challenges it as a valuable therapeutic target. It is, therefore, necessary to understand the mechanisms behind the signaling characteristics of this receptor in intracellular communication. This review provides an overview of the recent research progress on the various regulatory mechanisms of the CaSR in related cardiovascular diseases and the heart–kidney interaction; the associated common causes are also discussed.

19 May 2020 in Cell Biochemistry and Function
Verified
Journal Article
Closed access
PDF file
YXYimin Xie
Yimin Xie
JGJie Gu
Jie Gu
ZQZhenqian Qin
Zhenqian Qin
ZRZhen Ren
Zhen Ren
YWYanwei Wang
Yanwei Wang
BCBinghai Chen
Binghai Chen

1 November 2023 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
HCHezhen Chu
Hezhen Chu
WXWenchao Xie
Wenchao Xie
CGChuanzhi Guo
Chuanzhi Guo
HSHaifeng Shi
Haifeng Shi
Jie GuJie Gu
Jie Gu
YXYimin Xie
Yimin Xie
Background: Our previous study has suggested that blocking stanniocalcin 2 (STC2) could reduce sunitinib resistance in clear cell renal cell carcinoma (ccRCC) under normoxia. The hypoxia is a particularly important environment for RCC occurrence and development, as well as sunitinib resistance. The authors proposed that STC2 also plays important roles in RCC sunitinib resistance under hypoxia conditions. Methods: The ccRCC Caki-1 cells were treated within the hypoxia conditions. Real-time quantitative PCR and Western blotting were applied to detect the STC2 expression in ccRCC Caki-1 cells. STC2-neutralizing antibodies, STC2 siRNA, and the recombinant human STC2 (rhSTC2) were used to identify targeting regulation on STC2 in modulating sunitinib resistance, proliferation, epithelial-mesenchymal transition (EMT), migration, and invasion. In addition, autophagy flux and the lysosomal acidic environment were investigated by Western blotting and fluorescence staining, and the accumulation of sunitinib in cells was observed with the addition of STC2-neutralizing antibodies and autophagy modulators. Results: Under hypoxia conditions, sunitinib disrupted the lysosomal acidic environment and accumulated in Caki-1 cells. Hypoxia-induced the STC2 mRNA and protein levels in Caki-1 cells. STC2-neutralizing antibodies and STC2 siRNA effectively aggravated sunitinib-reduced cell viability and proliferation, which were reversed by rhSTC2. In addition, sunitinib promoted EMT, migration, and invasion, which were reduced by STC2-neutralizing antibodies. Conclusion: Inhibiting STC2 could reduce the sunitinib resistance of ccRCC cells under hypoxia conditions.